BIOMAT Database Logo BIOMAT Database Logo

[High dosage therapy with stem cell transplantation in neuroendocrine carcinoma]. 2000

V Buxhofer, and R Ruckser, and P Kier, and K H Habertheuer, and P Zelenka, and G Tatzreiter, and S Dorner, and H Vedovelli, and C Sebesta, and W Hinterberger
Ludwig Boltzmann-Institut für Stammzelltransplantation an der 2. Medizinischen Abteilung des Donauspitals im SMZ-Ost der Stadt Wien.

Neuroendocrine carcinoma and small-cell lung cancer (SCLC) are highly responsive to chemo- and radiotherapy. Nevertheless, most patients (pts.) experience relapse. At the 2nd department of medicine in the Donauspital, 4 pts. with neuroendocrine carcinomas of different primary sites underwent high-dose chemotherapy with autologous stem-cell transplantation (ASTx). Pt. 1 suffered from neuroendocrine lung cancer, pt. 2 from a small-cell carcinoma of the pancreas. Pt. 3 had a metastatic small-cell abdominal bulky tumor and pt. 4 presented with neuroendocrine carcinoma of the prostate. After 4-6 cycles induction chemotherapy pts. were consolidated with 1 cycle of HDCht and ASTx. Prior to HDCht pt. 1 and pt. 2 were in complete remission (CR) and pt. 3 and pt. 4 in partial remission. Pt. 3 converted in CR after HDCht. He is still in CR with a disease-free survival of 23 month after ASTx and 30 month after diagnosis. Pt. 1, 2 and 4 died from relapse 10, 16 and 5 month after ASTx and 16, 22 and 9 month after diagnosis. Pts. with neuroendocrine carcinomas might be suitable candidates for HDCht and ASTx.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D018288 Carcinoma, Small Cell An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7) Carcinoma, Oat Cell,Oat Cell Carcinoma,Small Cell Carcinoma,Carcinomas, Oat Cell,Carcinomas, Small Cell,Oat Cell Carcinomas,Small Cell Carcinomas

Related Publications

V Buxhofer, and R Ruckser, and P Kier, and K H Habertheuer, and P Zelenka, and G Tatzreiter, and S Dorner, and H Vedovelli, and C Sebesta, and W Hinterberger
[High dosage chemotherapy and peripheral blood stem cell transplantation in breast carcinoma].
January 1998, Zentralblatt fur Chirurgie,
V Buxhofer, and R Ruckser, and P Kier, and K H Habertheuer, and P Zelenka, and G Tatzreiter, and S Dorner, and H Vedovelli, and C Sebesta, and W Hinterberger
[Electronic data processing-assisted high dosage therapy with stem cell transplantation at the Donauspital].
January 1995, Wiener medizinische Wochenschrift (1946),
V Buxhofer, and R Ruckser, and P Kier, and K H Habertheuer, and P Zelenka, and G Tatzreiter, and S Dorner, and H Vedovelli, and C Sebesta, and W Hinterberger
[High dose therapy with stem cell transplantation].
November 1998, Der Internist,
V Buxhofer, and R Ruckser, and P Kier, and K H Habertheuer, and P Zelenka, and G Tatzreiter, and S Dorner, and H Vedovelli, and C Sebesta, and W Hinterberger
High-Dose Therapy and Stem Cell Transplantation.
October 1998, Cancer control : journal of the Moffitt Cancer Center,
V Buxhofer, and R Ruckser, and P Kier, and K H Habertheuer, and P Zelenka, and G Tatzreiter, and S Dorner, and H Vedovelli, and C Sebesta, and W Hinterberger
High-dose therapy and stem cell transplantation.
April 2010, Seminars in hematology,
V Buxhofer, and R Ruckser, and P Kier, and K H Habertheuer, and P Zelenka, and G Tatzreiter, and S Dorner, and H Vedovelli, and C Sebesta, and W Hinterberger
[A randomized phase-II study of high-dosage chemotherapy with stem-cell transplantation in women with operable infraclavicular metastatic breast carcinoma].
February 1999, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
V Buxhofer, and R Ruckser, and P Kier, and K H Habertheuer, and P Zelenka, and G Tatzreiter, and S Dorner, and H Vedovelli, and C Sebesta, and W Hinterberger
Endocrine complications of high-dose therapy with stem cell transplantation.
June 2004, Pediatric transplantation,
V Buxhofer, and R Ruckser, and P Kier, and K H Habertheuer, and P Zelenka, and G Tatzreiter, and S Dorner, and H Vedovelli, and C Sebesta, and W Hinterberger
High-dose therapy with stem-cell transplantation in the malignant lymphomas.
December 1999, Oncology (Williston Park, N.Y.),
V Buxhofer, and R Ruckser, and P Kier, and K H Habertheuer, and P Zelenka, and G Tatzreiter, and S Dorner, and H Vedovelli, and C Sebesta, and W Hinterberger
High CD34 positive stem cell dosage improves thrombocyte recovery in obese myeloma patients undergoing autologous stem cell transplantation.
December 2021, Leukemia & lymphoma,
V Buxhofer, and R Ruckser, and P Kier, and K H Habertheuer, and P Zelenka, and G Tatzreiter, and S Dorner, and H Vedovelli, and C Sebesta, and W Hinterberger
[High-dosage cytostatica therapy in breast carcinoma].
December 1970, Langenbecks Archiv fur Chirurgie,
Copied contents to your clipboard!